ABAT and metabolic dysfunction-associated steatotic liver disease: Using an ensemble feature selection approach, this study successfully identified key biomarkers, including ABAT, C8B, FBXL3, and ZFP1, providing valuable insights into NAFLD to HCC disease progression.